+775.4%
HBAN vs GSK
+1,657.0%
-881.5%
-95.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.6% | -2.7% | +1.1% | -0.6% |
| 7D | +2.1% | -4.2% | +6.3% | +3.6% |
| 30D | -4.5% | -7.5% | +3.0% | -1.9% |
| 3M | +2.6% | -3.3% | +5.8% | +3.4% |
| 6M | +4.7% | -9.3% | +14.1% | +8.0% |
| YTD | -1.5% | +1.6% | -3.1% | -2.8% |
| 1Y | -1.9% | +25.5% | -27.4% | -10.9% |
| 3Y | +75.2% | +49.3% | +25.9% | +45.4% |
| 5Y | +37.2% | +46.7% | -9.5% | +12.8% |
| 10Y | +156.6% | +76.8% | +79.8% | +93.4% |
| All | +775.4% | +1,657.0% | -881.5% | +315.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling